Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...
GlaxoSmithKline's GSK treatment to reduce exacerbations in chronic obstructive pulmonary disease patients was approved by the U.S. Food and Drug Administration. The Research Triangle park, N.C., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback